Data Mesh in Healthcare: Domain-Owned Data Products

Data mesh in healthcare means each clinical or business domain (laboratory, cardiology, pharmacy, revenue cycle) owns and publishes its own analytical data as a product, while a central platform team supplies shared tooling and a governance council sets enterprise rules such as PHI masking and retention. It suits multi-hospital systems where a single central data team has become the bottleneck, and it usually sits on top of a lakehouse rather than replacing it.

The typical multi-hospital health system runs a centralized data warehouse managed by a small analytics team. Every department (cardiology, laboratory, pharmacy, and billing) submits requests to this team for new datasets, reports, and pipelines. The result is a request queue, stale data, and clinicians who resort to building shadow spreadsheets.

Data mesh, a paradigm introduced by Zhamak Dehghani of Thoughtworks in a May 2019 article, offers an alternative. Instead of funneling all data through a central team, data mesh distributes ownership to the clinical domains that understand the data best. Each domain publishes data products: curated, documented, quality-monitored datasets with defined SLAs, that other teams can discover and consume independently.

For hands-on help with this, see our healthcare data engineering.

Data mesh is also an operating model. For healthcare organizations managing data across multiple hospitals, clinics, and specialties, data mesh addresses fundamental problems: data ownership ambiguity, cross-departmental trust, regulatory compliance at scale, and the chronic bottleneck of centralized data teams. This guide covers how to implement data mesh principles in a healthcare setting, with concrete examples from clinical domains.

Data Mesh in Healthcare: What Changes From Other Industries

Data mesh in healthcare keeps the ideas Zhamak Dehghani set out in 2019: domain ownership, data as a product and a self-serve platform. What changes is the setting, because patient privacy, patient identity and vendor-run source systems shape most of the design work.

• Privacy rules travel with the data. The HIPAA minimum necessary standard asks covered entities to limit protected health information to what a purpose needs (45 CFR 164.502(b)). A shared platform can apply the same masking and access rules in every domain.
• One patient can hold many records. A patient seen at two hospitals may have two medical record numbers, so data products need a shared patient matching service before they can be joined.
• Domains rarely run their source systems. Lab and cardiology data often sits in an EHR or departmental system that central IT manages. The domain owns the meaning and quality of its data product, while interface work may stay shared.

If You Are Deciding Whether Data Mesh Fits Your Health System

This section is for the CIO, chief data officer or VP of data and analytics who owns the analytics budget and has to choose between hiring more central data engineers, buying another platform, or changing who owns the data. The fears we hear are the same each time: a two-year program that ends as a new monolith, a HIPAA finding because PHI masking differs between departments, lock-in to one cloud or catalog vendor, and clinical leaders who never take ownership.

Data mesh is a good fit when three things are true: you run more than one hospital or many specialties, a single central team receives most data requests, and at least one department (often laboratory or revenue cycle) has people who already understand its data. It is a poor fit for a single small hospital with one analytics team that is keeping up. In that case, a well-governed lakehouse is enough.

Four questions settle the decision: Which domain gets the most requests? Who in that domain will own a data product and its service level? Does your catalog tag PHI today? Can access rules be enforced by the platform rather than by each team?

Estimate Your Own Return Before You Start

The first gain from data mesh is central data engineering time released from routine requests that a domain team could serve itself. You can estimate it with numbers you already have:

Annual hours released = monthly requests to the central team x average hours per request x 12 x share of requests a domain product would serve.
Estimated annual value = hours released x loaded hourly cost.

Worked example (an estimate, not a result): 120 requests a month, 6 hours each, and a pilot domain that would serve 30% of them gives 120 x 6 x 12 x 0.30 = 2,592 hours a year. At the US Bureau of Labor Statistics May 2024 median wage for database administrators and architects of $59.18 an hour, that is about $153,400 a year in wages alone. Add your benefits load (often 1.3 to 1.4 times wage in your own HR figures) for a loaded cost. Compare it with the cost of the pilot domain team and platform work. Count only requests your ticket system shows, and measure the real share after Phase 2 rather than assuming it.

Source for the wage default: BLS Occupational Outlook Handbook, Database Administrators and Architects, pay data for May 2024 (bls.gov/ooh/computer-and-information-technology/database-administrators.htm). Request volume, hours per request and the domain share are your inputs.

How We Do It

We start with your request log, not with a tool choice. In the first two to three weeks we count where requests come from, by department, and which datasets they touch. That shows which domain should go first and which two or three data products would serve the most requests.

We then write the contract for the first product (schema, freshness, completeness, PHI class, consumers) and build it on the platform you already run, whether that is Databricks, Snowflake or AWS. We ingest FHIR Bulk Data, HL7 v2 and X12, and publish flattened analytical tables with FHIR references kept for traceability. On our own engineering page we plan six to ten weeks for a first data product and two to four weeks for hardening and handover.

Pitfalls we see often: the platform team quietly starts cleaning domain data and becomes the bottleneck again; masking rules live in a document instead of in the access engine; FHIR resources are used as the warehouse model and queries slow down at population scale; and test pipelines are fed with copies of production PHI. We avoid the last one by building on synthetic, PHI-free test data from the start.

What We Have Built That You Can Check

• healthcare-test-data-lab: PHI-free FHIR and HL7 v2 test data built from Synthea, with quality gates, for testing pipelines without patient data.
• x12-fhir-mapper: maps X12 837 and 835 claims to FHIR R4 through a neutral model, the kind of contract a revenue cycle domain publishes.
• hipaa-spring-boot-starter: field-level encryption, audit trail and minimum-necessary access control as platform behaviour.
• headless-ehr-fhir: FHIR R4 platform with ABAC authorization and bulk $export.
• Real-time clinical dashboards with FHIR and Superset: a consumer-side build on FHIR data.

The Four Principles of Data Mesh Applied to Healthcare

1. Domain Ownership

In a data mesh, the team closest to the data owns it end-to-end. In healthcare, this maps directly to clinical departments:

• Cardiology owns cardiac data: echocardiogram results, cath lab reports, cardiac device data (pacemakers, ICDs), and risk scores (ASCVD, CHA2DS2-VASc)
• The laboratory owns lab data: chemistry panels, microbiology cultures, pathology results, critical value alerts, and reference range management
• The pharmacy owns medication data: prescribing patterns, formulary compliance, drug interaction alerts, dispensing records, and controlled substance tracking
• Revenue Cycle owns financial data: claims lifecycle, denial analytics, charge capture completeness, payment posting, and revenue leakage analysis

Each domain team includes data engineers who build and maintain pipelines, analysts who understand the clinical context, and a domain data product owner who defines priorities and SLAs.

2. Data as a Product

A data product is a curated, documented, quality-monitored dataset designed for consumption by other teams. Every healthcare data product must include:

• Schema definition: Clear structure, often aligned with FHIR or OMOP standards
• Quality SLAs: Freshness guarantees (e.g., lab results within 15 minutes of validation), completeness thresholds (99.5% coded with LOINC), accuracy metrics
• Documentation: Auto-generated schema docs, data dictionary, example queries, known limitations
• Access controls: Role-based access with PHI-appropriate masking (clinicians see full data, researchers see de-identified)
• Discoverability: Listed in a shared data catalog where any team can find and evaluate it

3. Self-Serve Data Infrastructure Platform

Domain teams should not each build their own infrastructure from scratch. The platform team provides shared, standardized tools that reduce the cognitive load of publishing data products:

4. Federated Computational Governance

Healthcare cannot have ungoverned data. HIPAA, state privacy laws, and accreditation requirements demand enterprise-wide controls. Data mesh solves this with federated governance: enterprise standards that all domains must follow, combined with domain-level autonomy for implementation details.

# federated-governance-policy.yaml
# Enterprise-wide standards (mandatory for all domains)
enterprise_standards:
  data_format:
    clinical: "FHIR R4 or OMOP CDM v5.4"
    financial: "X12 EDI or custom with documented schema"
    interoperability: "All data products must expose FHIR-compatible APIs"

  phi_classification:
    levels:
      - restricted: "Direct identifiers (name, SSN, MRN)"
      - sensitive: "Quasi-identifiers (DOB, ZIP, dates of service)"
      - de-identified: "Safe harbor or expert determination applied"
    default: "restricted"  # assume PHI until classified

  retention:
    hipaa_documentation: "6 years (45 CFR 164.316: policies, procedures, required assessments)"
    medical_records: "set by state law and payer contracts; HIPAA sets no medical record period"
    minors: "state-dependent; often extended past age of majority"
    automated_purging: true

  access_control:
    authentication: "SSO via enterprise IdP (SAML/OIDC)"
    authorization: "RBAC + ABAC (attribute-based for PHI)"
    audit: "all PHI access logged, 6-year retention"
    break_the_glass: "emergency override with mandatory justification"

  quality:
    minimum_completeness: 0.95
    freshness_sla_required: true
    validation_on_publish: true

# Domain-specific policies (autonomy within guardrails)
domain_policies:
  cardiology:
    device_data_handling: "21 CFR Part 11 controls where records fall under FDA requirements (e.g. device studies)"
    imaging_format: "DICOM with FHIR ImagingStudy wrapper"

  laboratory:
    critical_values: "immediate notification pipeline required"
    reference_ranges: "age/sex stratified, updated quarterly"

  pharmacy:
    controlled_substances: "DEA Schedule II-V tracking"
    formulary: "updated within 24h of P&T committee decisions"

  revenue_cycle:
    payer_rules: "payer-specific validation before submission"
    coding_standards: "ICD-10-CM/PCS current year, CPT updated annually"

Healthcare Domain Examples: What Data Products Look Like

Cardiology Domain Data Products

The cardiology data team publishes four core data products that downstream consumers (population health, quality reporting, research) depend on:

# cardiology_data_products.py
# Domain: Cardiology | Owner: Cardiac Data Engineering Team

CARDIOLOGY_DATA_PRODUCTS = {
    "echo_results": {
        "name": "Echocardiogram Results",
        "description": "Structured echo findings including LVEF, "
                       "wall motion, valve assessments, and measurements",
        "schema": "FHIR DiagnosticReport + Observation components",
        "freshness_sla": "within 2 hours of final read",
        "quality_metrics": {
            "completeness": 0.98,  # 98% of echo reports have structured LVEF
            "coding": "LOINC for all measurement types",
            "validation": "LVEF 10-80%, chamber dimensions within physiologic range"
        },
        "access": {
            "clinician": "full",
            "researcher": "de-identified, IRB approval required",
            "quality_team": "aggregate metrics only"
        },
        "consumers": [
            "Heart Failure Registry",
            "Quality Reporting (CMS Star Ratings)",
            "Population Health Dashboard",
            "Surgical Planning Team"
        ],
        "update_frequency": "streaming (real-time from echo PACS)",
        "storage": "Delta Lake bronze -> silver -> gold"
    },

    "cardiac_risk_scores": {
        "name": "Cardiac Risk Score Calculations",
        "description": "Pre-computed risk scores: ASCVD 10-year risk, "
                       "CHA2DS2-VASc (stroke risk in AF), HEART score (ACS)",
        "schema": "FHIR RiskAssessment resources",
        "freshness_sla": "recalculated daily at 02:00 UTC",
        "quality_metrics": {
            "completeness": 0.92,  # 92% of eligible patients have current scores
            "validation": "scores within published ranges, input completeness check"
        },
        "consumers": [
            "CDS Hooks (real-time alerts)",
            "Population Health Stratification",
            "Value-Based Care Risk Adjustment"
        ]
    },

    "cath_lab_reports": {
        "name": "Catheterization Lab Procedure Reports",
        "description": "Structured cath lab data: coronary anatomy, "
                       "interventions, hemodynamics, complications",
        "schema": "FHIR Procedure + Observation",
        "freshness_sla": "within 4 hours of procedure completion",
        "quality_metrics": {
            "completeness": 0.99,
            "coding": "CPT for procedures, SNOMED for findings"
        }
    },

    "device_telemetry": {
        "name": "Cardiac Device Remote Monitoring",
        "description": "Pacemaker and ICD remote monitoring data: "
                       "device checks, arrhythmia episodes, lead measurements",
        "schema": "FHIR DeviceMetric + Observation",
        "freshness_sla": "daily batch from device vendor APIs",
        "regulatory": "audit-trailed storage; 21 CFR Part 11 where records fall under FDA requirements"
    }
}

Laboratory Domain Data Products

# laboratory_data_products.py
# Domain: Laboratory | Owner: Lab Informatics Team

LABORATORY_DATA_PRODUCTS = {
    "lab_results": {
        "name": "Validated Lab Results",
        "description": "All validated lab results with LOINC coding, "
                       "reference ranges, and interpretive flags",
        "schema": "FHIR Observation (laboratory category)",
        "freshness_sla": "within 15 minutes of LIS validation",
        "quality_metrics": {
            "loinc_coverage": 0.995,   # 99.5% LOINC coded
            "completeness": 0.99,      # 99% have reference ranges
            "units_standardized": True  # UCUM units throughout
        },
        "critical_value_pipeline": {
            "enabled": True,
            "notification_sla": "< 5 minutes from result to alert",
            "channels": ["EHR inbox", "pager", "SMS"],
            "escalation": "if unacknowledged in 30 min, page supervisor"
        },
        "consumers": [
            "Clinical Decision Support",
            "Population Health Analytics",
            "Quality Measures (HEDIS)",
            "Research Data Warehouse (OMOP measurement table)"
        ]
    },

    "trending_analytics": {
        "name": "Lab Result Trends and Analytics",
        "description": "Pre-computed trends: 90-day moving averages, "
                       "rate of change, predicted next value for chronic patients",
        "schema": "Custom analytics schema with FHIR Observation references",
        "freshness_sla": "recalculated within 1 hour of new result",
        "consumers": [
            "Chronic Disease Management Dashboard",
            "Physician mobile app trend views"
        ]
    }
}

Data Product Contract Template

Every data product must be published with a machine-readable contract. This contract serves as the interface between the producing domain and its consumers:

# data-product-contract.yaml
# Template for healthcare data product registration
apiVersion: datamesh.healthcare.io/v1
kind: DataProduct
metadata:
  name: lab-results-validated
  domain: laboratory
  owner: lab-informatics-team
  version: "2.3.0"
  last_updated: "2026-03-16"

spec:
  description: >
    Validated laboratory results from all hospital lab instruments.
    LOINC-coded with UCUM units and age/sex-stratified reference ranges.

  schema:
    format: "FHIR R4 Observation"
    profile: "http://hl7.org/fhir/us/core/StructureDefinition/us-core-observation-lab"
    storage: "Delta Lake (gold layer)"
    location: "s3://health-data-lake/gold/lab/results/"

  quality:
    freshness:
      sla: "15 minutes from LIS validation"
      measurement: "max(current_time - observation.effectiveDateTime)"
      alert_threshold: "30 minutes"
    completeness:
      target: 0.995
      critical_fields:
        - "code.coding[0].code"     # LOINC code
        - "valueQuantity.value"     # result value
        - "valueQuantity.unit"      # UCUM unit
        - "referenceRange"          # normal range
    accuracy:
      validation_rules:
        - "valueQuantity.value within 5 SD of population mean"
        - "effectiveDateTime not in future"
        - "status in (final, amended, corrected)"

  access:
    classification: "PHI - Restricted"
    roles:
      treating_clinician:
        access: "full"
        filter: "patient in care_team"
      researcher:
        access: "de-identified"
        requires: "IRB approval + DUA"
      quality_analyst:
        access: "aggregate"
        minimum_cell_size: 11
      billing:
        access: "CPT + diagnosis codes only"

  sla:
    availability: "99.9%"
    latency_p99: "< 200ms for single patient query"
    throughput: "10,000 records/second for bulk export"

  dependencies:
    upstream:
      - "lis-raw-results (bronze layer)"
      - "omop-vocabulary (concept mapping)"
    downstream:
      - "population-health-dashboard"
      - "clinical-decision-support"
      - "research-data-warehouse"

  compliance:
    hipaa: true
    retention: "10 years (state requirement)"
    audit_logging: true
    encryption: "AES-256 at rest, TLS 1.3 in transit"

Technical Implementation: Self-Serve Data Platform

Platform Architecture

# platform-infrastructure.yaml
# Self-serve data platform for healthcare data mesh
# Deployed via Terraform + Kubernetes

platform_services:

  data_catalog:
    tool: "DataHub (open-source) or Unity Catalog"
    features:
      - schema_discovery: "auto-crawl Delta Lake, FHIR server"
      - lineage_tracking: "end-to-end from source EHR to dashboard"
      - phi_tagging: "automated PII/PHI detection and classification"
      - search: "natural language search across all data products"
      - quality_scores: "data product health scores visible to consumers"

  quality_framework:
    tool: "Great Expectations + custom healthcare validators"
    checks:
      standard:
        - "schema conformance (FHIR profile validation)"
        - "completeness (critical field null rates)"
        - "freshness (time since last update vs SLA)"
        - "volume anomaly (sudden drops/spikes in record count)"
      clinical:
        - "vital signs within physiologic range"
        - "lab values within instrument reportable range"
        - "medication doses within FDA-approved range"
        - "age at event consistent with demographics"

  access_control:
    tool: "Apache Ranger or Immuta"
    policies:
      - type: "RBAC"
        description: "role-based access by job function"
      - type: "ABAC"
        description: "attribute-based for PHI (department, care team)"
      - type: "dynamic_masking"
        description: "SSN, DOB, name masked for non-clinical users"
      - type: "row_level_security"
        description: "researchers see only consented patients"

  pipeline_templates:
    available:
      - "fhir-ingestion"
      - "hl7v2-to-fhir"
      - "edi-claims-processing"
      - "device-telemetry-streaming"
      - "bulk-fhir-export"
    standard_stages:
      - "bronze: raw ingestion (immutable)"
      - "silver: cleaned, validated, PHI-tagged"
      - "gold: business-ready data products"

Implementing Data Product Discovery

# data_product_registry.py
# Central registry for data mesh data products
# Consumed by the data catalog UI

from dataclasses import dataclass, field
from typing import Optional
from datetime import datetime
import json

@dataclass
class QualitySLA:
    freshness_minutes: int
    completeness_target: float
    last_measured: Optional[datetime] = None
    current_freshness_minutes: Optional[float] = None
    current_completeness: Optional[float] = None

    @property
    def freshness_healthy(self) -> bool:
        if self.current_freshness_minutes is None:
            return False
        return self.current_freshness_minutes <= self.freshness_minutes

    @property
    def completeness_healthy(self) -> bool:
        if self.current_completeness is None:
            return False
        return self.current_completeness >= self.completeness_target


@dataclass
class DataProduct:
    name: str
    domain: str
    owner_team: str
    description: str
    schema_format: str
    storage_location: str
    quality_sla: QualitySLA
    phi_classification: str  # restricted, sensitive, de-identified
    consumer_count: int = 0
    version: str = "1.0.0"
    tags: list = field(default_factory=list)

    @property
    def health_score(self) -> float:
        """Calculate overall health score (0-100)."""
        score = 0
        if self.quality_sla.freshness_healthy:
            score += 40
        if self.quality_sla.completeness_healthy:
            score += 40
        if self.consumer_count > 0:
            score += 10
        if self.version != "1.0.0":
            score += 10  # mature product
        return score


# Example: Register lab results data product
lab_results = DataProduct(
    name="lab-results-validated",
    domain="laboratory",
    owner_team="Lab Informatics",
    description="Validated lab results with LOINC coding and reference ranges",
    schema_format="FHIR R4 Observation (US Core Lab Profile)",
    storage_location="s3://data-lake/gold/lab/results/",
    quality_sla=QualitySLA(
        freshness_minutes=15,
        completeness_target=0.995,
        current_freshness_minutes=8.2,
        current_completeness=0.997,
        last_measured=datetime(2026, 3, 16, 10, 0)
    ),
    phi_classification="restricted",
    consumer_count=12,
    version="2.3.0",
    tags=["clinical", "lab", "loinc", "fhir"]
)

print(f"Health Score: {lab_results.health_score}/100")
# Output: Health Score: 100/100

Organizational Change: The Hardest Part

Team Structure

Data mesh requires organizational change as well as technology. Each domain needs a small, embedded data team:

The platform team remains centralized but serves domains rather than controlling them. Their success metric is domain team productivity, not the number of pipelines they build themselves. This is the biggest change from a central data team.

Common Resistance and How to Address It

Implementation Roadmap

Phase 1: Foundation (Months 1-3)

• Identify 4-6 clinical domains and their data assets
• Establish a federated governance council (CIO, CISO, CMIO, domain leaders)
• Select and deploy a self-serve platform (data catalog, quality framework)
• Define enterprise standards: data formats, PHI classification, retention
• Choose pilot domain (recommendation: Laboratory, with the highest data volume, clearest ownership)

Phase 2: Pilot Domain (Months 4-6)

• Embed 2 data engineers in the pilot domain
• Publish first 2-3 data products (e.g., Lab Results, Critical Values, Trending)
• Register in the data catalog with full contracts
• Onboard 3-5 initial consumers (population health, quality reporting, research)
• Measure: time-to-data-access before vs. after

Phase 3: Scale (Months 7-12)

• Expand to 3-4 domains (add Cardiology, Pharmacy, Revenue Cycle)
• Deploy shared quality monitoring and SLA dashboards
• Implement cross-domain data products (e.g., patient journey combining lab + cardiology + pharmacy)
• Establish data product lifecycle management (versioning, deprecation, migration)

Phase 4: Maturity (Year 2+)

• All major domains are publishing data products
• Self-serve consumption: new data requests served by the owning domain from the catalog, with request turnaround tracked against the Phase 2 baseline
• Cross-domain analytics: population health, value-based care, research
• Data marketplace: internal teams can browse, evaluate, and subscribe to data products
• Automated compliance: PHI masking, retention, and audit applied by the platform

Data Mesh vs. Other Architectures for Healthcare

For most multi-hospital health systems, we recommend a hybrid approach: build a data lakehouse as the shared infrastructure platform, then overlay data mesh principles for domain ownership and governance.

Who Owns What: Domains, Platform Team and Governance Council

In the programs we review, unclear lines of responsibility are the most common reason work stalls. A simple split works for health systems:

The platform team provides compliant provisioning tools but does not own or clean domain data, and global policies are written by domain representatives and enforced automatically by the platform, for example masking patient identifiers for non-clinical users. Policy as code (tools such as Open Policy Agent) is how "computational" governance becomes real rather than a document on a shared drive.

Data Mesh on a Cloud Stack: A Reference Pattern

A common cloud pattern separates three accounts or workspaces: a producer per domain, a central governance account that holds the catalog and access rules, and consumer accounts for analytics and data science. On AWS, published reference designs use a FHIR store such as Amazon HealthLake for clinical data, AWS Lake Formation for central access control and auditing, the Glue Data Catalog for discovery, and Athena or QuickSight for consumption, with HIPAA-eligible services, customer-managed encryption keys, and masking for PHI. The same split maps to Databricks Unity Catalog or Snowflake with a tag-based policy engine.

Where FHIR Fits, and Where It Does Not

FHIR is the right contract for exchanging patient-level records between systems and for exposing data products through APIs. It is a poor analytical core on its own: deeply nested resources are slow to query at population scale. In practice, domains ingest FHIR and HL7v2, then publish analytical data products in flattened or OMOP-shaped tables, keeping FHIR references for traceability. Avoid two traps: making a transactional exchange standard your warehouse model, and rebuilding the old central monolith under a new name.

Beyond One Health System: Regional and National Data Mesh

The same principles scale past a single organization. Proposals for national health data meshes treat agencies, regional bodies, insurers and academic medical centers as nodes that each publish data products, guided by the FAIR principles (findable, accessible, interoperable, reusable), with a data council for federated governance. For a US multi-hospital system, the practical lesson is to design contracts and the catalog so that affiliated practices, HIEs and payers can become consumers later without rework.

Frequently Asked Questions

What is data mesh in healthcare?

It is an approach where clinical and business domains own their analytical data as products with defined quality SLAs, built on a shared self-serve platform and governed by enterprise-wide rules for PHI, access and retention.

Is data mesh compatible with HIPAA?

Yes. HIPAA requires safeguards, access controls and accountability, and it does not require one central data team. Federated governance enforces the same masking, minimum necessary access and audit logging in every domain through the platform.

How is data mesh different from a healthcare data lakehouse?

A lakehouse is storage and compute architecture. Data mesh is an ownership and governance model. Most health systems run data mesh on top of a lakehouse.

What is a good healthcare data architecture for a multi-hospital system?

A shared lakehouse platform with bronze, silver and gold layers, a catalog with PHI tags, FHIR and HL7v2 ingestion templates, and domain-owned data products for lab, cardiology, pharmacy and revenue cycle, governed by a federated council.

Which domain should go first?

Pick the domain with the most data requests and the clearest ownership. Laboratory and revenue cycle are usually strong candidates.

What does a data mesh program cost?

Most of the cost is people: a product owner and one or two engineers per domain, plus a shared platform team. Start with one domain and measure before funding more.

Do we need to replace our data warehouse or lakehouse?

No. Data mesh changes ownership and governance. Domains publish products on the platform you already run.

How do we avoid vendor lock-in?

Keep data product contracts in open formats (FHIR, OMOP, Delta or Iceberg tables) and keep policies as code, so the catalog or cloud can change without rewriting products.

How long until we see a first data product?

We plan six to ten weeks for the first product after a two to three week assessment.

Get a Data Mesh Readiness Assessment

A fixed-scope assessment over two to three weeks. You receive:

• A count of your data requests by domain, from your own ticket log
• A ranked list of the first three data products, each with a draft contract
• A gap check of your catalog, PHI tagging and access enforcement against the governance model above
• Your ROI estimate using the formula above with your numbers
• A written plan and budget for the pilot domain

You get a fixed quote after a short scoping call. Book a scoping call or see our healthcare data engineering services.

Related guides

• Healthcare Data Architectures Compared: Data Warehouse vs Data Lake vs Lakehouse vs Data Mesh
• Healthcare Data Governance: Lineage, Catalog, and Access Control for PHI at Scale
• FHIR to Databricks: Build a Recoverable ETL Pipeline
• Snowflake for Healthcare: Building a Clinical Data Warehouse with FHIR JSON and Secure Data Sharing